Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Armodafinil

Armodafinil

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Armodafinil

31 trials tracked of Armodafinil: 17 in phase 3 or 4 and 1 with published results. The most-cited published study has 37 citations.

31Trials tracked
17Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 8 Phase 3 9 Phase 2 12 Other / NA 2
  1. Phase 4 Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder Completed · 37 cited
  2. Phase 4 Effect of Nuvigil on Fatigue Completed
  3. Phase 4 Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance Completed
  4. Phase 4 Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression Completed
  5. Phase 4 Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder Completed
  6. Phase 4 Effectiveness of Armodafinil for Treating Fatigue in Adults With HIV/AIDS Completed
Show 25 more trials
  1. Phase 4 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed
  2. Phase 4 "Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies" Completed
  3. Phase 3 Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder Completed
  4. Phase 3 Impact of Armodafinil on Neurocognition and Cognitive Fatigue in Multiple Sclerosis (MS) Completed
  5. Phase 3 A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma Completed
  6. Phase 3 Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy Completed
  7. Phase 3 Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder Completed
  8. Phase 3 Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder Completed
  9. Phase 3 Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia Completed
  10. Phase 3 A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder Completed
  11. Phase 3 Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome Completed
  12. Phase 2 PET Study Examining the Dopaminergic Activity of Armodafinil in Adults Completed
  13. Phase 2 Management of Insomnia in Breast Cancer Patients Completed
  14. Phase 2 Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive Deficits Completed
  15. Phase 2 A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Completed
  16. Phase 2 Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia Completed
  17. Phase 2 Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke Completed
  18. Phase 2 Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer Completed
  19. Phase 2 Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors Completed
  20. Phase 2 A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer Completed
  21. Phase 2 Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder Completed
  22. Phase 2 Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss Completed
  23. Phase 2 Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy Completed
  24. N/A A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil Completed
  25. N/A The Treatment of Insomnia Comorbid With Sleep Disordered Breathing Using Armodafinil and/or Cognitive Behavioral Therapy for Insomnia Completed

Showing the 31 most-cited and recently-updated of 31 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.